oral semaglutide approval FDA Sets Action Date for Wegovy for Weight Loss In Brief: Rybelsus R2 Rebranded

Diabetes, Obes

Someone who loses 50 pounds in five months may experience more pronounced adaptation than someone who loses the same amount over twelve months

The Sublingual Format Direct Meds' Unique Needle-Free Option The sublingual format is the most distinctive feature of Direct Meds' medication offering and the one that makes the platform meaningfully different from the majority of compounded GLP-1 telehealth providers currently operating

The regulatory requirements differ significantly

That third target is the same one tirzepatide uses, and its generally believed to improve tolerability of the GLP-1 effect while contributing its own metabolic benefit